Refers to any of the Food and Drug Administration (FDA) procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials.

See also:
Food And Drug Administration